Parkwood LLC’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Parkwood LLC’s Portfolio NVACR Stock Details NVACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000,000	Closed	-$20K	–	99
2024 Q4	$20K	Hold	1,000,000	–	–	﹤0.01%	84
2024 Q3	$51K	Hold	1,000,000	–	–	﹤0.01%	80
2024 Q2	$102K	Hold	1,000,000	–	–	0.01%	118
2024 Q1	$150K	Hold	1,000,000	–	–	0.01%	172
2023 Q4	$87K	Hold	1,000,000	–	–	0.01%	123
2023 Q3	$170K	Hold	1,000,000	–	–	0.02%	129
2023 Q2	$120K	Hold	1,000,000	–	–	0.02%	122
2023 Q1	$170K	Hold	1,000,000	–	–	0.02%	137
2022 Q4	$172K	Hold	1,000,000	–	–	0.03%	135
2022 Q3	$75K	Hold	1,000,000	–	–	0.01%	139
2022 Q2	$105K	Buy	+1,000,000	New	+$131K	0.02%	134

Other funds holding NVACR

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Parkwood LLC's NVACR Position: Q1 2025 in Review

Parkwood LLC sold out of NorthView Acquisition Corporation Rights (NVACR) in Q1 2025, closing a stake of 1,000,000 shares — an estimated $20K sold.

Parkwood LLC first reported a position in NVACR in Q2 2022 and held it in 11 quarters. The position peaked at $172K in Q4 2022. 1 fund tracked by Wall St. Rank holds NVACR as of Q1 2025.

Parkwood LLC reported no remaining NorthView Acquisition Corporation Rights position as of Q1 2025 after selling out during the quarter.
Parkwood LLC sold 1,000,000 NorthView Acquisition Corporation Rights shares in Q1 2025, an estimated $20K.
Parkwood LLC first reported a position in NorthView Acquisition Corporation Rights in Q2 2022 and held it in 11 quarters.
Parkwood LLC's NorthView Acquisition Corporation Rights position peaked at $172K in Q4 2022.
1 fund tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q1 2025.

Based on Parkwood LLC's 13F filing for Q1 2025, filed 15 May 2025.